Arkolith/Insider Trading/FUSN/Form 4

Bergstrom Donald A

DirectorFusion Pharmaceuticals Inc. (FUSN) · full profile →Form 4 · filed Jun 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 4, 2024Disposed to issuer(D)34K——0
Jun 4, 2024Disposed to issuer(D)17K——0
Jun 4, 2024Disposed to issuer(D)17K——0
Jun 4, 2024Disposed to issuer(D)17K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-068867) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML